Form 4 for EVH Evolent Health, Inc.
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001628908-22-000039 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-03 | 2022-03-01 | EVH | Johnson John Paul | CFO | A - Grant | $0.00 | +24.0K | 160.9K | +18% | $0 | |
| 2022-03-03 | 2022-03-01 | EVH | Johnson John Paul | CFO | F - Tax | $27.40 | -4,510 | 156.4K | -3% | -$123.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-03-01 | A | A | 24,000 | $0.00 | 160,921 | D | — | — | (F1) Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. (F2) Securities vest at a rate of 34% on March 1, 2023, and 33 % on March 1, 2024, and March 1, 2025. (F3) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |
| 2 | Common | Class A Common Stock | 2022-03-01 | F | D | 4,510 | $27.40 | 156,411 | D | — | — | (F4) This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. (F3) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |